Full Text
PMU74 - POTENTIAL COST SAVINGS BY PREVENTION OF ADVERSE DRUG EVENTS WITH A NOVEL MEDICATION REVIEW PROGRAM

Abstract

Authors

EV Fernández CL Warriner TN David EA Gordon S Jackson G Twigg NV Carroll

Back to Volume 21, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×